論文・総説 - 田中　一

41. Uchida Y, Yokoyama M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujiwara T, Fujii Y. Preservation of Erectile and Ejaculatory Functions After Tetramodal Bladder-Sparing Therapy Incorporating Consolidative Partial Cystectomy Against Muscle Invasive Bladder Cancer. Urology research & practice. 2023.05; 49 (3): 162-168. ( PubMed, DOI )

42. Nakamura Yuki, Fukushima Hiroshi, Yoshitomi Kasumi, Soma Takahiko, Kobayashi Masaki, Fan Bo, Fujiwara Motohiro, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Fujii Yasuhisa. 筋層非浸潤性膀胱癌の増悪予測における背側膀胱頸部浸潤の重要性(Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer) International Journal of Urology. 2023.04; 30 (4): 381-388. ( 医中誌 )

43. Fujiwara M, Yoshida S, Takahara T, Soma T, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yokoyama M, Fujii Y. Prostate and metastasis diffusion volume based on apparent diffusion coefficient as a prognostic factor in Hormone-naïve prostate Cancer. Clinical & experimental metastasis. 2023.04; 40 (2): 187-195. ( PubMed, DOI )

44. Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study. International journal of urology : official journal of the Japanese Urological Association. 2023.03; 30 (3): 258-263. ( PubMed, DOI )

45. Fujiwara Motohiro, Yokoyama Minato, Toide Masahiro, Fujiwara Ryo, Tanaka Hajime, Oguchi Tomohiko, Komai Yoshinobu, Yoshida Soichiro, Matsuoka Yoh, Numao Noboru, Yamamoto Shinya, Fukui Iwao, Yonese Junji, Fujii Yasuhisa. 筋層浸潤性膀胱癌患者に対する最大限の経尿道的切除術、導入化学放射線療法、地固め部分膀胱切除術からなる選択的4者併用膀胱温存療法後の腎機能転帰と根治的膀胱全摘術後の腎機能転帰との比較　2施設後ろ向き研究(Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study) Japanese Journal of Clinical Oncology. 2023.03; 53 (3): 263-269. ( 医中誌 )

46. Chen Wei, Yokoyama Minato, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Nonomura Norio, Fujii Yasuhisa. 根治的膀胱摘除術の動向およびロボット支援根治的膀胱摘除術に注目した外科的アプローチ間の手術成績の比較　日本の全国データベース研究(Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study) International Journal of Urology. 2023.03; 30 (3): 258-263. ( 医中誌 )

47. Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study. Japanese journal of clinical oncology. 2023.03; 53 (3): 263-269. ( PubMed, DOI )

48. Yoshida, S; Takahara, T; Arita, Y; Ito, M; Hayakawa, S; Oguchi, T; Komai, Y; Numao, N; Yuasa, T; Inoue, M; Ushijima, H; Kudo, S; Shimano, Y; Nakamura, Y; Uchida, Y; Uehara, S; Tanaka, H; Yaegashi, H; Izumi, K; Yokoyama, M; Matsuoka, Y; Yoshioka, Y; Konishi, K; Nakanishi, K; Nagahara, A; Hirakawa, A; Koike, R; Koga, F; Nishimura, K; Mizokami, A; Yonese, J; Kageyama, Y; Yoshimura, R; Fujii, Y. A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL) BMC UROLOGY. 2023.03; 23 (1): 33. ( PubMed, DOI )

49. Hajime Tanaka, Shohei Fukuda, Koichiro Kimura, Yuki Fukawa, Kouhei Yamamoto, Hiroshi Fukushima, Shingo Moriyama, Yosuke Yasuda, Sho Uehara, Yuma Waseda, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Ukihide Tateishi, Steven C Campbell, Yasuhisa Fujii. Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell Carcinoma. Eur Urol Open Sci. 2023.02; 48 36-43. ( PubMed, DOI )

50. Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma. BJU international. 2023.02; 131 (2): 219-226. ( PubMed, DOI )

51. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Fujiwara M, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy. International journal of urology : official journal of the Japanese Urological Association. 2023.02; 30 (2): 204-210. ( PubMed, DOI )

52. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Kimura Koichiro, Fujiwara Motohiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Progressive site-directed therapyを施行したgenuineおよびinduced oligometastasisを伴う去勢抵抗性前立腺癌の再発パターン(Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive sitedirected therapy) International Journal of Urology. 2023.02; 30 (2): 204-210. ( 医中誌 )

53. Yuki Nakamura, Hiroshi Fukushima, Kasumi Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii. Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. Int J Urol. 2022.12; 30 (4): 381-388. ( PubMed, DOI )

54. Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study Int J Urol. 2022.12;

55. Julia H Yuan, Hajime Tanaka, Dattatraya Patil, Kevin Hakimi, Shady Soliman, Margaret F Meagher, Ava Saidian, Arman Walia, Sohail Dhanji, Franklin Liu, Jonathan Afari, Mimi Nguyen, Luke Wang, Yosuke Yasuda, Kazutaka Saito, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR. Clin Genitourin Cancer. 2022.12; 21 (4): e219-e227. ( PubMed, DOI )

56. Keiner C, Meagher M, Patil D, Saito K, Walia A, Liu F, Dutt R, Miller N, Dhanji S, Saidian A, Wan F, Yasuda Y, Fujii Y, Tanaka H, Master V, Derweesh I.. Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis Front Oncol. 2022.11; ( DOI )

57. Yamaguchi Y, Yokoyama M, Takemoto A, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma. IJU case reports. 2022.11; 5 (6): 480-483. ( PubMed, DOI )

58. Yamaguchi Yoshitomo, Yokoyama Minato, Takemoto Akira, Nakamura Yuki, Fukuda Shohei, Uehara Sho, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Fujii Yasuhisa. コハク酸脱水素酵素欠損性腎細胞癌を合併したコハク酸脱水素酵素欠損性の悪性パラガングリオーマ(Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma) IJU Case Reports. 2022.11; 5 (6): 480-483. ( 医中誌 )

59. Shimada Wataru, Kimura Koichiro, Tanaka Hajime, Fukuda Shohei, Yoshida Soichiro, Fujii Yasuhisa. 不規則な腫瘍形の重要性　cT1b-2N0M0腎細胞癌のpT3aへのステージ上昇を予測するためのダイナミックCTに基づくラジオミクス解析(Significance of tumor shape irregularity: Radiomics analysis based on dynamic computed tomography for predicting pT3a upstaging in cT1b-2N0M0 renal cell carcinoma) International Journal of Urology. 2022.11; 29 (11): 1387-1389. ( 医中誌 )

60. Tanaka H, Fujii Y. Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma Int J Urol. 2022.08; 29 (8): 822-823.